News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Flexion Therapeutics (FLXN) Announces Changes To Board Of Directors


6/12/2014 7:37:20 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BURLINGTON, Mass., June 12, 2014 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today recent changes to its Board of Directors. Ann Merrifield, President and CEO of PathoGenetix, Inc., has been appointed to the Board, effective June 11, 2014. In addition, Flexion Board of Directors members Bradley Bolzon, Ph.D., Versant Ventures, and Elaine Jones, Ph.D., Pfizer Venture Investments, are stepping down from the Board effective immediately.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES